Content area
Full text
Welcome to the final issue of volume 8 of Pharmaceutical Patent Analyst! In this Forewordwe will discuss some of the highlights that the journal has seen over the last year as well as what there is to expect in 2020. We are grateful to our authors, editorial board members, peer reviewers and readers - we look forward to continuing to work with all of our contributors again in 2020.
Content highlights for 2019 Our ongoing series of Patent Highlights has once again proved popular over theyear. In these articles, Herman Mucke has provided an up to date snapshot of recent noteworthy developments in patent literature with relevance to pharmaceutical and medicinal research and development (1-5). One of our most read articles of the year was ‘International collaboration generates high quality clusters of pharmaceutical patents’ (6). In this Review, Christian Moser, Swiss Federal Institute of Intellectual Property (Bern, Switzerland), provided an overview of the current pharmaceutical patent landscape with respect to its qualitative aspects, concluding that patents originating from international collaborations generally yield a higher impact when compared with one-sided publications. In addition to this, Richard A Cerione, Cornell University (NY, USA), provided a popular article concerning the current patent landscape of the inhibition of cancer metabolism (7). In this Patent Review, the authors give an overview of small-molecule inhibitors which target cancer progression - with a focus on inhibitors of glycolysis, anaplerosis, the tricarboxylic acid cycle and nutrient import - along...